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Abstract
Endogenous pain modulation may provide facilitation or inhibition of nociceptive input by three main mechanisms. Firstly,
modiﬁcation of synaptic strength in the spinal dorsal horn may increase or decrease transmission of nociceptive signals to the
brain. Secondly, local dorsal horn interneurons provide both feed-forward and feed-back modulation to spinothalamic and
spinobulbar projection neurons. Thirdly, descending systems originating in the brainstem exert top-down modulation of noci-
ceptive input at the spinal level. Not much is known on the activity of these systems in complex regional pain syndrome (CRPS).
CRPS is a chronic pain condition characterized by burning pain and abnormalities in the sensory, motor and autonomous nervous
system. In the present study, we tested changes in endogenous pain modulation in 27 CRPS patients compared with age-
matched healthy controls. We applied repetitive noxious electrical stimuli (stimulation frequency 1Hz) at the dorsal aspect of
affected and unaffected hands in patients and to corresponding hands in controls. As known from previous studies this protocol
simultaneously activates inhibitory and facilitatory pain modulating systems. This results in adaptation to the repetitive noxious
stimulus, and simultaneously and at the same site, in development of an area of pinprick hyperalgesia. We measured (i) pain
adaptation during the course of stimulation and (ii) the provoked area of pinprick hyperalgesia. These parameters were used as
activity measures of pain inhibitory and pain facilitatory systems. As both measures result from gross inhibitory and gross
facilitatory activity in pain modulatory systems, pain adaptation reﬂects net pain inhibition and area of pinprick hyperalgesia net
pain facilitation. We found (i) decreased adaptation to painful electrical stimuli on both affected and unaffected hands of CRPS
patients compared to healthy controls and (ii) increased areas of hyperalgesia on affected hands of CRPS patients compared to
unaffected hands of CRPS patients and healthy controls. These ﬁndings imply a shift from inhibition towards facilitation of
nociceptive input in CRPS patients, based on differential activation of subcomponents of the endogenous pain modulatory
system. The differences were not correlated with duration of the disease, pain intensity, autonomic or motor function scores,
presence or degree of evoked pain. However, signiﬁcant correlation was found with the extent of adaptation and hyperalgesia
on the unaffected hand. Thus, we hypothesize that differential activity in endogenous pain modulating systems may be not only
a result of CRPS, but a potential risk factor for its development.
Keywords: descending pain control; pain modulation; CRPS; RSD; neuropathic pain; electrical model; hyperalgesia; allodynia;
inhibition; facilitation; brainstem
Abbreviations: AA=adaptation affected hand; AU=adaptation unaffected hand; CRPS=complex regional pain syndrome;
EDT=electrical detection threshold; EPT=electrical pain threshold; HAA=hyperalgesic area affected hand; HAU=hyperalgesic
area unaffected hand; LDI=laser Doppler imaging; LTD=long-term depression; LTP=long-term potentiation; MDT=mechanical
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 detection threshold; MPQ=McGill pain questionnaire; MPT=mechanical pain threshold; PAG=periaqueductal grey;
RVM=rostroventral medulla
Introduction
Individual differences in endogenous pain modulation are dis-
cussed as a risk factor for the development of chronic pain
(Edwards, 2005). On the other hand chronic pain states could
impact on the activity or capacity of endogenous pain modulating
systems. There are three known main mechanisms of endogenous
pain modulation. Firstly, mechanisms of long-term potentiation
(LTP) and long-term depression (LTD) of synaptic strength in the
spinal dorsal horn have been shown to result in modiﬁed trans-
mission of nociceptive signals in animals (Sandkuhler et al., 1997;
Ikeda et al., 2003, 2006; Sandkuhler, 2007). These synaptic
mechanisms have been also suggested to result in increased or
decreased pain perception in humans (Klein et al., 2004;
Sandkuhler, 2007). LTP and LTD are ubiquitous mechanisms of
synaptic plasticity. LTP phenomena within the somatosensory
system have been shown to occur after conditioning stimuli of
peptidergic C-nociceptor terminals and lamina I projection neurons
expressing the neurokinin-1 receptor (Ikeda et al., 2003, 2006).
There is evidence from human psychophysical studies that the
perceptual correlate of LTP in the nociceptive system is secondary
mechanical hyperalgesia (Klein et al., 2004, 2006; Lang et al.,
2007). LTD phenomena can be induced by low-frequency noxious
stimulation (Sandkuhler et al., 1997; Chen and Sandkuhler, 2000)
and are believed to have their perceptual correlate in a decrease in
pain perception mediated by the conditioned pathway (Klein
et al., 2006). As a second modulatory mechanism there are
dorsal horn inhibitory interneurons that utilize GABA, glycine or
opioids and provide both feed-forward and feed-back inhibition to
the spinothalamic and spinobulbar projection neurons (Basbaum
and Fields, 1984; Millan, 2002; Benarroch, 2008). Thirdly, des-
cending systems originating in the brainstem can inhibit or facili-
tate peripheral nociceptive input in the dorsal horn. Chronic pain
states may also depend on descending control that originate in the
brain (Urban and Gebhart, 1999b; Pertovaara, 2000; Porreca
et al., 2002; Ren and Dubner, 2002). The midbrain periaqueductal
gray (PAG) and the rostroventral medulla (RVM) are key struc-
tures of the endogenous descending pain modulatory system
(Basbaum and Fields, 1978, 1984). As the PAG itself has limited
direct projections to the spinal cord (Sandkuhler and Gebhart,
1984), it uses the RVM as a site that projects directly to the
spinal dorsal horn. Therefore, RVM is an important intermediate
in pain modulation (Basbaum and Fields, 1984; Starowicz et al.,
2007). Descending projections from the PAG to the RVM and
from the RVM to dorsal horn neurons are thought to regulate
nociceptive input at the spinal level (Proudﬁt and Anderson,
1975; Basbaum and Fields, 1978; Behbehani and Fields, 1979;
Sandkuhler and Gebhart, 1984). This PAG to RVM to dorsal
horn axis seems to form the backbone of the endogenous pain
modulatory outputs (Mason, 2005). Both PAG and RVM receive
input from prefrontal and cingulate cortices (Valet et al., 2004),
anterior insular cortex (Hardy and Leichnetz, 1981), amygdala
(Gray and Magnuson, 1992) and hypothalamus (Beitz, 1982),
allowing differential regulation of activity in the pain modulatory
system by cognitive or affective processes (Reynolds, 1969; Akil
et al., 1976; Boivie and Meyerson, 1982). However, the descend-
ing pain control system has not only an inhibitory component. It
also facilitates peripheral nociceptive input (Millan, 2002).
Inﬂammation (Kidd and Urban, 2001; Klein et al., 2005) or neuro-
pathy (Woolf and Mannion, 1999) can induce primary or second-
ary hyperalgesia. Primary hyperalgesia is characterized by
increased painfulness to heat and static pressure of the injured
tissue (Koltzenburg et al., 1992; Schmelz et al., 2000), secondary
hyperalgesia manifests with increased painfulness to pinprick stim-
uli in the surrounding tissues (Ziegler et al., 1999). For experimen-
tal repetitive transcutaneuous electrical stimulation only secondary
hyperalgesia has been shown (Koppert et al., 2001, 2005).
Secondary hyperalgesia is a product of an increase in the excit-
ability of nociceptive spinal neurons (central sensitization). Thus,
descending modulation by PAG and RVM of nociceptive input is a
mixture of inhibition (Ren and Dubner, 2002) and facilitation
(Urban and Gebhart, 1999a; Porreca et al., 2002) with facilitation
predominating in areas in secondary hyperalgesia (Vanegas,
2004). For a detailed review see Millan (2002).
Complex regional pain syndromes (CRPS) may develop after limb
trauma. The disease is characterized by sensory, autonomic and
motor symptoms (Stanton-Hicks et al., 1995). The leading sensory
symptoms are spontaneous and evoked pain, but hypoesthesia can
also occur. The autonomic dysfunctions may consist of temperature
changes, trophic disturbances, skin colour changes, oedema or
sweating abnormalities. Motor symptoms include paresis, tremor
and dystonia (Birklein, 2005). It can be differentiated between
CRPS types I and II. CRPS type I is diagnosed when there is no
obvious nerve injury, whereas CRPS type II refers to cases with
nerve injury (Stanton-Hicks et al., 1995; Birklein, 2005). Although
the pathogenesis of the syndrome is not completely understood,
there is evidence for neurogenic inﬂammation (Birklein et al.,
2001; Weber et al., 2001), endothelial dysfunction
(Schattschneider et al., 2006b), pathological sympathico-afferent
coupling (Baron et al., 2002; Schattschneider et al., 2006a) and
CNS changes (Janig and Baron, 2002). As a major pathophysiologi-
cal aspect the CNS changes include pain-induced neuroplasticity.
Reorganization of somatotopic maps within the primary somatosen-
sory cortex has been shown in CRPS patients by neuroimaging
techniques (Maihofner et al., 2003, 2004; Pleger et al., 2005).
Cortical reorganization correlates with the individual area of
mechanical hyperalgesia and perceived spontaneous pain and can
be reversed by treatment (Maihofner et al., 2003, 2004). Thus,
CRPS is more than a pain syndrome, it is a multisystemic disease
with neurophysiolgical manifestations at all levels of the neuraxis.
However, nothing is known about disturbances in endogenous
pain modulating systems in CRPS. Therefore, we performed the
present study to test the hypothesis of a differential endogenous
pain modulation in CRPS patients. In particular, we applied repet-
itive noxious electrical stimuli at the dorsal aspect of affected and
unaffected hands in patients and to corresponding hands
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 in controls. Based on previous studies, we chose conditioning high-
current-density electrical stimuli preferably activating mechano-
insensitive C-nociceptors (Schmelz et al., 2000). This paradigm
has been shown to provoke (i) well controllable pain, (ii) stable
areas of pinprick hyperalgesia reﬂecting activation of facilitatory
mechanisms and (iii) activation of an endogenous naloxone-
sensitive inhibitory system reducing pain and hyperalgesia
(Koppert et al., 2001, 2005). In addition, it facilitates a nalox-
one-insensitive inhibitory system that mainly acts antihyperalgesic
(Koppert et al., 2001, 2005). If endogenous pain modulation is
impaired in CRPS patients these changes might reﬂect a pre-exist-
ing risk factor for CRPS occurrence or a result of the CPRS
manifestation.
Methods
Subjects
A total of 27 patients with clinically diagnosed CRPS (9 males, 18
females, mean age 57.6 years2.56) and 14 healthy age-matched
controls (3 males, 11 females, mean age 52.8 years3.43 years)
participated in the study. The patients had to meet the current IASP
diagnostic criteria for CRPS (Stanton-Hicks et al., 1995). These criteria
were extended to the IASP research criteria (Harden et al., 2007) so
that at least four symptoms (at least one in each category: sensory,
vasomotor, sudomotor/oedema, motor/trophic) must be reported by
the patient and at least one sign must been present in two or more
sign categories (sensory, vasomotor, sudomotor/oedema, motor/
trophic) at time of evaluation. This results in a speciﬁcity of 0.94
(Harden et al., 2007). Patients and controls had to be 18 years or
older. Exclusion criteria for the controls were history of any neurolog-
ical disease or chronic pain and use of analgesics during the week
before the experiment. The patients and controls were informed
about the procedures of the study but were unaware of the speciﬁc
experimental goals. Informed consent was obtained from all partici-
pants before the experiments. The study adhered to the tenets of the
Declaration of Helsinki and was approved by the local ethics commit-
tee. The stimulation site was the back of the hand in all subjects.
Study design
Initially we performed (i) baseline measurements for mechanical and
electrical detection and pain thresholds, followed by (ii) a 16-min
equilibration phase in which the current was adapted every 2min to
a numeric rating scale (NRS) rating of 6 (NRS 0–10). Subsequently (iii)
the adaptation to the repetitive stimuli was measured over 30min. The
current was constant over this time, pain ratings (NRS 0–10) were
obtained every minute. After the adaptation period the (iv) measure-
ments for mechanical detection and pain thresholds were performed
again and the (v) presence and extent of an axon reﬂex ﬂare was
determined by laser Doppler imaging. Furthermore, the (vi) areas of
experimental pinprick hyperalgesia were measured.
Assessment of pain and quantitative
sensory testing for CRPS induced
pinprick hyperalgesia
Spontaneous CRPS pain was quantiﬁed using the German counterpart
(Stein and Mendl, 1988) of the McGill questionnaire (MPQ).
Patients were instructed to ﬁll in the MPQ (i) regarding the sponta-
neous pain for the time 1h previous to the experiment and (ii) regard-
ing the spontaneous pain averaged over the last 4 weeks. In addition,
patients quantiﬁed (i) their spontaneous pain for the time 1h previous
to the experiment and (ii) their spontaneous pain averaged over the
last 4 weeks on a 11-point NRS, ranging from 0 (no pain) to 10
(intolerable pain).
Induction of electrically induced
hyperalgesia
Transcutaneous electrical stimulation was used to induce ongoing pain
and secondary mechanical hyperalgesia as described previously
(Koppert et al., 2001, 2005; Filitz et al., 2008). Brieﬂy, two self-
adhesive electrodes were mounted on the skin at 4mm distance on
the back of the hand. Monophasic, rectangular electrical pulses of
0.5ms duration were applied via a constant current stimulator
(Digitimer S7, Digitimer, Hertfordshire, UK) at 1Hz. The current was
gradually increased during the ﬁrst 16min of stimulus administration,
targeting a pain rating of 6 on an 11-point numeric rating scale (NRS;
0=no pain and 10=maximum tolerable pain), and was then kept
constant for the remaining time of the experiment. This experimental
approach has been proven to provoke stable areas of secondary
hyperalgesia to punctate stimuli caused by an activation of primarily
mechano-insensitive C-nociceptors (Schmelz et al., 2000). This class of
nociceptors was shown to be electrically activated preferentially at
high current densities as used in this model (Weidner et al., 1999).
Psychophysical testing
Psychophysical testing was performed to assess the following para-
meters: (i) mechanical detection threshold (MDT), (ii) mechanical
pain threshold (MPT), (iii) electrical detection threshold (EDT), (iv)
electrical pain threshold (EPT) and (v) area of pinprick hyperalgesia.
The MDT and MPT were determined before and after the stimulation
period as described in detail in (Rolke et al., 2006). Brieﬂy, MDT was
measured with a standardized set of modiﬁed von Frey hairs (Optihair-
Set, Marstock Nervtest, Germany) that exert forces upon bending
between 0.25 and 512mN graded by a factor of 2 (1s contact
time). Using the ‘method of limits’, 5 threshold determinations were
made, each with a series of ascending and descending stimulus inten-
sities. The ﬁnal threshold was the geometric mean of these ﬁve series.
MPT was measured before and after electrical stimulation using
custom-made weighted pinprick stimuli as a set of seven pinprick
mechanical stimulators with ﬁxed stimulus intensities that exerted
forces of 8, 16, 32, 64, 128, 256 and 512mN. Measurements were
done at the site of electrical stimulation. The stimulators were applied
for 12s in an ascending order until the ﬁrst perception of pain was
reached. The ﬁnal threshold was the geometric mean of ﬁve series of
ascending and descending stimuli. The EDT and EPT were measured
only before the stimulation period by slowly increasing the current
until the stimulus was detected (EDT) or the ﬁrst percept of pain
was reached (EPT). Areas hyperalgesic to pinprick were assessed
before and after the stimulation period using a 256mN pinprick sti-
mulator. The borders of the hyperalgesic areas were delineated by
testing pinprick sensitivity along eight linear paths (separated by an
angle of 45) parallel and vertical to the axis of the hand from distant
starting points towards the stimulation site (step size 0.5cm) until the
subject reported increased pain sensations evoked by the pinprick.
Pain modulation in complex-regional pain syndrome Brain 2009: Page 3 of 13 | 3
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 Laser-Doppler-imaging
We used a laser Doppler imager (LDI, Moor, London, UK) to assess
the axon reﬂex ﬂare in parallel to the psychophysical protocol after
transcutaneous repetitive electrical stimulation as described above. A
rectangular skin area around the stimulation site was scanned at a
distance of 30cm with a twodimensional spatial resolution of
0.5mm. Laser Doppler scans were taken three times at 10min inter-
vals after the stimulation period. The size of the axon reﬂex ﬂare
erythema was analysed ofﬂine using dedicated software (MLDI 3.8,
Moor, UK). The ﬂare area was deﬁned as the number of pixels that
had a ﬂux value exceeding the mean ﬂux of all pixels in the control
scan (before stimulation) by 2 SDs, as described before (Namer et al.,
2005).
Correlation analysis
In order to correlate the obtained adaptation curves and hyperalgesic
areas with clinical parameters we calculated z-scores of (i) the electrical
induced pain intensity at the end of the adaptation phase (NRS minute
46 of electrical stimulation) and (ii) the hyperalgesic area (in cm
2)b y
calculating the z-transform: Z=(valuepatientmeangroup)/SDgroup. The
z-scores of (i) adaptation and (ii) hyperalgesic area were tested for
correlation with (a) each other (b) the z-score of adaptation of the
contralateral hand; (c) the z-score of the hyperalgesic area of the
contralateral hand; (d) the CRPS duration; (e) pain intensity obtained
by the numeric rating scale regarding: (1) spontaneous pain for the
time 1h previous to the experiment and (2) spontaneous pain aver-
aged over the last 4 weeks; (f) pain intensity obtained by the pain
rating index (PRI) of the German counterpart of the MPQ regarding:
(1) spontaneous pain for the time 1h previous to the experiment and
(2) spontaneous pain averaged over the last 4 weeks; (g) the sum
score of motor symptoms; (h) the sum score of autonomic distur-
bances; (i) medications used at the day of the experiment: (1) tricyclic
antidepressants, (2) opioids, (3) gabapentin and pregabalin, (4) NSAID;
(j) age. Pearson product moment correlation coefﬁcient was used.
Bonferroni correction for multiple testing was applied.
Statistical analysis
The data are presented as meanSEM. Statistical evaluation was per-
formed using the STATISTICA software package. The data obtained
from both hands of the control group were pooled together for further
analysis. For analysis of MDTs and MPTs of the different groups an
antilog function was applied to all individual thresholds before further
statistical analysis. ANOVA with the two factors ‘group’ (levels: CRPS
affected, CRPS unaffected, control) and ‘time’ (levels: pre, post) was
performed. Post hoc Bonferroni test was used. For statistical analysis of
the course of adaptation to the repetitive stimuli ANOVA was per-
formed with three factors: ‘group (levels: CRPS, control)’, ‘side (levels:
left, right, affected, unaffected)’ and ‘time (levels: 30 time points)’.
Again, post hoc Bonferroni test was used. To test for a covariance of
the different individual currents (at the beginning of the experiment
due to different pain sensitivity, and at the end of the 16min equili-
bration period due to additional individual differences of adaptation
during the equilibration period) ANCOVA with the following covari-
ates (continuous predictor) was performed: (i) the current at beginning
of the experiment and (ii) the normalized current at the end of the
16min equilibration period. To assess statistically signiﬁcant differences
between hyperalgesic areas for inter-group comparisons the U-test
and for intra-group comparisons the Wilcoxon matched pairs test
was used. P50.05 were considered to be statistically signiﬁcant.
Results
Characterization of patients and
controls
CRPS patients
A detailed clinical characterization of the CRPS patients can be seen in
Table 1. The mean age of the patients was 57.62.56 years which
was not different compared to the control group (P40.05). Twenty-
two patients had CRPS I, three had CRPS II. The mean CRPS-duration
was 22.124.3 months. Nine of the patients were males and 18
were females. The affected side was the left hand in 16 patients
and the right hand in 11 patients. All of the patients reported spon-
taneous pain. The mean pain on a numeric rating scale (NRS; from
0 to 10) and mean MPQ PRI during the previous 4 weeks was
4.660.38/ 21.772.40, the mean NRS (0–10) and mean MPQ
PRI during the hour previous to the experiment was 3.780.44/
15.302.30. Pinprick hyperalgesia was present in 24 of the patients,
dynamic mechanical allodynia was present in 21 of the patients.
Motor symptoms were present in 23 patients, autonomic disturbances
were seen in all of the patients (details see Table 1). The mean pinprick
hyperalgesic area of the affected hand was 39.36.74% of the total
hand surface. The distribution of areas of pinprick hyperalgesia and
dynamic-tactile allodynia is depicted in Fig. 1.
Healthy controls
The mean age of the control group (3 males, 11 females, mean
age 52.83.43 years) was 52.83.43 years. None of the con-
trols reported spontaneous pain. Pinprick hyperalgesia or dynamic
mechanical allodynia were not present.
Psychophysical measurements
Pain and tactile thresholds
EDTs before stimulation, MDTs and MPTs before and after stim-
ulation are depicted in Table 2. In detail, EDTs were (i) signiﬁcantly
higher in the CRPS affected hand group compared with the CRPS-
unaffected hand group (P50.05). For analysis of MDTs and MPTs
of the different groups ANOVA with the two factors ‘group’
(levels: CRPS affected, CRPS unaffected, control) and ‘time’
(levels: pre, post) was performed. For MDTs there was (ii) a sig-
niﬁcant effect of the factor group (P=0.005, ANOVA) with a
higher MDT in ‘CRPS affected’ compared with ‘control’
(P=0.004, Bonferroni test), there was no signiﬁcant difference
between ‘CRPS unaffected’ and ‘control’ (P=0.18, Bonferroni
test) and ‘CRPS affected’ and ‘CRPS unaffected’ (P=0.48,
Bonferroni test). We also found (iii) a signiﬁcant effect of the
factor time (P50.0001, ANOVA) with a higher MDT in the
post-condition (P50.0001, Bonferroni test). There was no signif-
icant interaction of the factors group and time (P=0.73, ANOVA).
Post hoc comparison revealed (iv) a signiﬁcant difference between
the pre- and the post-condition in all three groups (controls
P=0.010, CRPS affected P=0.034, CRPS unaffected P=0.0011,
Bonferroni test). There was no signiﬁcant difference between the
pre-conditions of the different groups (P40.05, Bonferroni test)
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 Table 1 Demographic data, diagnoses, symptoms and treatment of patients
Patient
No.
Age
(years)
Gender Diagnosis CRPS
hand
Inciting
event
NRS/PRI
initial
NRS/PRI
1-h-pre
NRS/PRI
4-weeks-
pre
Touch Mechanical
hyperalgesia
Allodynia Cold
hyper-
senstivity
Motor
symptoms
Autonomic
disturbances
Time
from
onset
(months)
Medication Comorbidity
1 75 Female CRPS I Left Distal radius
fracture
4/13 2/7 5/17 Normal + + + Paresis Hair/nails 
Skin temp. +
oedema
15 Pregabalin Diabetes
Hypertension
2 80 Female CRPS I Right Shoulder
luxation
6/34 3/17 7/33 Hypesthesia + + + Paresis Reddish skin 3 / Hypertension
3 46 Male CRPS I Left Hand surgery 9/49 6/32 8/36 Hypesthesia + + + Dystonia Oedema
reddish skin
2 Opioid,
amityptilin
/
4 62 Female CRPS I Left Metacarpus
fracture
8/21 2/6 5/13 Hypesthesia + + + Tremor Oedema
white skin
7 NSAID /
5 70 Female CRPS I Left Minor injury 5/12 4/2 5/11 Hypesthesia  +  Paresis White skin
oedema
6 Gabapentin
prednisolone
Hypertension
low back pain
6 48 Female CRPS I Left Proximal
forearm
fracture
9/17 0/0 3/25 Normal + Tremor Oedema
sweating +
7/ /
7 65 Female CRPS I Left Humerus
fracture
6/16 5/0 5/8 Hypesthesia + + + Paresis Reddish skin 13 Pregabalin Hypertension
Osteoporosis
Low back pain
8 75 Female CRPS I Left Distal radius
fracture
8/9 2/6 3/7 Normal +  + Paresis Oedema
sweating +
15 / /
9 61 Female CRPS I Left Distal radius
fracture +
ulna fracture
4/16 5/14 5/17 Normal  + + Paresis Reddish skin
hair/nails +
oedema
3 Opioid
calcitonin
methylprenisolone
/
10 42 Male CRPS I Left Metacarpus
fracture
7/33 7/24 7/39 Hypesthesia + + + Paresis Cyanotic skin
hair/nails +
oedema
sweating +
20 NSAID
opioid
amititylin
Low back pain
hypertension
11 69 Female CRPS II Left Surgery for
carpal tunnel
syndrome
7/34 3/8 3/15 Hypesthesia + +  / Oedema 17 / Hypertension
Diabetes
12 56 Male CRPS I Right Hand surgery 5/12 5/33 5/27 Normal + +  Paresis Reddish skin
skin temp.+
Oedema
sweating +
72 / Coronary
heart
disease
13 64 Male CRPS I Left Minor injury 9/24 5/27 6/31 Hypesthesia + + + / Oedema 16 NSAID Hypertension
14 74 Male CRPS I Left Minor injury 4/26 2/16 2/17 Hypesthesia +  + Tremor Cyanotic skin
hair/nails+
oedema
sweating +
30 / /
15 52 Female CRPS I Left Hand surgery 4/27 4/25 3/38 Hypesthesia + + + Paresis
Initiation
problem
White skin
hair/nails-
oedema
10 NSAID /
16 41 Male CRPS I Right Metacarpus
fracture
5/40 0/0 0/0 Normal +  + Paresis White skin
oedema
31 Opipramol /
17 63 Female CRPS I Right Distal radius
fracture
5/14 6/9 6/13 Hypesthesia +  + Paresis Reddish skin 28 Hypertension
Tremor hair/nails +
oedema
sweating 
18 37 Female CRPS I Left Hand surgery 7/6 5/42 4/24 Hypesthesia + + + / Sweating + 24 Paracetamol
opioid
pregabalin
Low back pain
(continued)
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 Table 1. Continued
Patient
No.
Age
(years)
Gender Diagnosis CRPS
hand
Inciting
event
NRS/PRI
initial
NRS/PRI
1-h-pre
NRS/PRI
4-weeks-
pre
Touch Mechanical
hyperalgesia
Allodynia Cold
hyper-
senstivity
Motor
symptoms
Autonomic
disturbances
Time
from
onset
(months)
Medication Comorbidity
19 41 Female CRPS I Right Epicondylitis
humeri
radialis
9/51 10/28 10/49 Hypesthesia + + + Paresis
Tremor
Myoklonus
Cyanotic skin
hair/nails +
oedema
sweating +
6 NSAID
Opioid
Gabapentin
/
20 56 Female CRPS II Right Surgery for
carpal
tunnel
syndrome
4/25 4/3 5/26 Normal + + + Paresis
Tremor
Cyanotic skin
sweating +
30 / Hypertension
21 54 Male CRPS I Right Radius and
ulna fracture
5/22 4/14 4/12 Hypesthesia + +  Paresis Oedema 34 / Hypertension
22 60 Female CRPS I Right Distal radius
fracture
5/29 1/3 3/10 Normal + +  Tremor Cyanotic skin
hair/nails +
oedema
sweating +
17 / Hypertension
23 73 Female CRPS II Right Surgery for
carpal
tunnel
syndrome
7/30 0/33 5/45 Normal + / Hair/nails +
oedema
sweating +
36 / /
24 43 Male CRPS I Left Distal radius
fracture
7/43 3/23 3/30 Hyperesthesia + +  Paresis
Tremor
Initiation
problem
Oedema 96 NSAID /
25 69 Female CRPS I Right Distal radius
fracture
6/31 4/11 4/15 Normal + + + Paresis Cyanotic skin
hair/nails+
skin temp.+
oedema
sweating+
15 / Low
back pain
26 36 Female CRPS I Right Distal radius
fracture
5/12 5/12 5/12 Hypesthesia + +  Paresis Oedema
reddish skin
5 NSAID /
27 42 Male CRPS I Left Distal radius
fracture
5/18 5/18 5/18 Hypesthesia + +  Paresis Oedema
reddish skin
4 NSAID /
NRS=numeric rating scale; PRI=pain rating index of the McGill pain questionaire; NSAID=non steroidal anti-inﬂammatory drugs; /=not present.
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 and no signiﬁcant difference between the post-conditions of the
different groups (P40.05, Bonferroni test). For MPTs there was
(v) a signiﬁcant effect of the factor group (P=0.049, ANOVA)
with a lower MPT in ‘CRPS affected’ compared with ‘control’
(P=0.0478, Bonferroni test), but there was no signiﬁcant differ-
ence between ‘CRPS unaffected’ and ‘control’ (P=0.38,
Bonferroni test) and ‘CRPS affected’ and ‘CRPS unaffected’
(P40.05, Bonferroni test). We also found (vi) a signiﬁcant effect
of the factor time (0.001, ANOVA) with a higher MPT in the post-
condition (P=0.001, Bonferroni test). There was no signiﬁcant
interaction of the factors group and time (P=0.78, ANOVA).
Post hoc comparison revealed no signiﬁcant difference between
the pre- and the post-condition in all three groups (P40.05,
Bonferroni test). There was also no signiﬁcant difference between
the pre-conditions of the different groups (P40.05, Bonferroni
test) and no signiﬁcant differences between the post-conditions
of the different groups (P40.05, Bonferroni test). Figure 2 sum-
marizes the corresponding MDTs and MPTs in CRPS patients com-
pared controls before and after the electrical stimulation.
Pain adaptation
The normalized current during the equilibration period and the
pain ratings during the adaptation period are depicted in Fig. 3.
Firstly, the normalized current needed to maintain a pain rated
NRS=6 was not signiﬁcantly different between the three groups
(i.e. control group, CRPS affected hand group, CRPS unaffected
hand group) at the beginning of the experiment (P=0.29,
ANOVA). There was a signiﬁcant increase in current needed to
maintain a pain rating of 6 in all three groups together (i.e.
control group, CRPS affected hand group, CRPS unaffected
hand group) (P50.0001, ANOVA). Also a signiﬁcant interaction
of the factors group and time was present (P=0.039, ANOVA).
However, post hoc comparisons for group or hand effects were
not signiﬁcant (P40.05, Bonferroni tests). Secondly, during the
adaptation period signiﬁcantly less adaptation was found for the
CRPS patients compared with the control group. There was a
signiﬁcant effect of the factor group (P=0.013, ANOVA) with
signiﬁcant less adaptation in CRPS patients compared to controls
(P=0.013, Bonferroni test). Interestingly, there was no signiﬁcant
Table 2 Mechanical detection and pain thresholds
EDT pre EPT pre MDT pre MDT post MPT pre MPT post
Control 1.480.08 3.800.28 8.141.59 13.863.07 310.8244.70 267.0943.20
CRPS Ipsi 1.620.13 4.310.47 28.045.96 47.1010.43 213.6042.93 148.9933.34
CRPS contra 1.320.04 4.160.37 15.583.09 40.2911.98 278.1147.67 221.8446.08
P50.05, post hoc Bonferroni test. MeansSEM.
Fig. 1 Distribution of areas of pinprick hyperalgesia (coded red) and areas of dynamic-tactile allodynia (coded yellow) in the
affected hands of the patients. Areas with both, pinprick hyperalgesia and dynamic-tactile allodynia are coded orange. The
patient numbers refer to Table 1.
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 difference between the affected and the unaffected hand in CRPS
patients: there was no signiﬁcant effect of the factor side
(P=0.45, ANOVA), with no signiﬁcant differences between the
affected and the unaffected hand of patients or left and right
hand of controls (P40.05, Bonferroni test). The effect of the
factor time was signiﬁcant (P50.0001, ANOVA), with signiﬁcantly
lower pain ratings in the course of stimulation (P50.05,
Bonferroni test). There was a signiﬁcant interaction of the factors
‘group’ and ‘time’ (P=0.007, ANOVA). Post hoc Bonferroni test
did not reveal signiﬁcantly different pain ratings between the two
groups at single time points (P40.05, Bonferroni test).
To test for a covariance of the different individual currents (at
the beginning of the experiment due to different pain sensitivity,
and at the end of the 16min equilibration period due to additional
individual differences of adaptation during the equilibration
period) ANCOVA with the following covariates (continuous pre-
dictor) were performed: (i) the current at beginning of the exper-
iment and (ii) the normalized current at the end of the 16min
equilibration period. A signiﬁcant difference was found for the
comparison of pain adaptation in CRPS patients versus controls
with both covariates [(i) current at beginning of the experiment
P=0.0062, ANCOVA; (ii) normalized current at the end of the
16min equilibration period P=0.018, ANCOVA]. The covariate
(i) current at beginning of the experiment had no signiﬁcant
effect (P=0.25, ANCOVA). The covariate (ii) normalized current
at the end of the 16min equilibration period had a signiﬁcant
effect (P50.0001, ANCOVA) on the following course of pain
adaptation. Those subjects with a high adaptation (upregulation
Fig. 3 (A) Adaptation curves during the initial equilibration phase. The normalized currents were equal on the affected and the
unaffected hand in CRPS patients and in healthy controls. MeansSEM. (B) Pain ratings during the adaptation phase. Mean adap-
tation was signiﬁcantly decreased in CRPS patients. P50.05, post hoc Bonferroni test. MeansSEM. (C) Hyperalgesic areas. Areas of
pinprick hyperalgesia for those subjects displaying hyperalgesia were signiﬁcantly different between (i) between the affected hand in
CRPS patients and healthy controls and (ii) the CRPS affected hand and the unaffected hand in CRPS Patients. P50.05, U-test for
inter-group comparisons and Wilcoxon matched pairs test for intra-group comparisons. MeansSEM.
Fig. 2 (A) Mechanical detection and (B) pain thresholds before and after the stimulation. P50.05, post hoc Bonferroni test.
MeansSEM.
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 of current to maintain a stable level of pain) in the equilibration
period had also high adaptation in the following course of adapta-
tion. The initial current needed to induce the targeted pain rating
however has no effect of the adaptation course.
For analysis of pain adaptation of the 24 patients with CRPS I
alone a subgroup analysis was performed. Thus, the three patients
with CRPS II were excluded from the analysis. Comparing this
subgroup to controls there was also a signiﬁcant effect of the
factor ‘group’ with signiﬁcantly decreased adaptation in CRPS I
patients (P=0.043, ANOVA).
Hyperalgesic areas
The area of electrically induced pinprick hyperalgesia as measured
10min post-stimulation is presented in Fig. 3C. Areas of pinprick
hyperalgesia were present 10min after stimulation in 64% of con-
trols (n=16 of 25 measurements), in 67% (n=18 of 27) of CRPS
patients on the affected hand and in 70% (n=19 of 27) of CRPS
patients on the unaffected hand. The area of pinprick hyperalgesia
in individuals displaying hyperalgesia was signiﬁcantly greater in
CRPS patients on the affected hand compared with controls
(P50.05; U-test) and to the unaffected hand (P50.05;
Wilcoxon matched pairs test). The area was 8.031.18cm
2 for
the control group, 12.721.36cm
2 for the CRPS affected hand
group and 7.801.44cm
2 for the CRPS unaffected hand group.
Laser Doppler imaging
Axon-reﬂex ﬂare
The area of the axon reﬂex ﬂare did not differ between the three
groups. In the CRPS affected hand group it was 2.20.4cm
2,i n
the CRPS unaffected hand group it was 2.60.5cm
2 and in the
control group it was 2.10.4cm
2 (P40.05 for all comparisons,
U-test and Wilcoxon matched pairs test, respectively).
Correlation analysis
The z-scores of (i) adaptation and (ii) hyperalgesic area were
tested for correlation among each other, with clinical characteris-
tics of the CRPS and with the experimentally obtained data.
No signiﬁcant correlation (P50.05) of these both parameters was
found (i) among each other [adaptation and hyperalgesic area
affected hand (HAA) r=0.18, unaffected hand r=0.08]; for (ii)
the CRPS duration [adaptation affected hand (AA) r=0.28,
HAA r=0.27, adaptation unaffected hand (AU) r=0.12,
hyperalgesic area unaffected hand (HAU) r=0.08]; (iii) pain inten-
sity obtained by the numeric rating scale regarding: (a) spontane-
ous pain for the time 1h previous to the experiment and (AA
r=0.05, HAA r=0.04, AU r=0.30, HAU r=0.04); (b) sponta-
neous pain averaged over the last 4 weeks NRS (AA r=0.21, HAA
r=0.18, AU r=0.14, HAU r=0.02); (iv) pain intensity obtained
by the PRI of the German counterpart of the MPQ regarding:
(a) spontaneous pain for the time 1h previous to the experiment
(AA r=0.08, HAA r=0.23, AU r=0.12, HAU r=-0.11) and
(b) spontaneous pain averaged over the last 4 weeks (AA r=0.04,
HAA r=0.11, AU r=0.20, HAU r=0.14); (v) the sum score
of motor symptoms (AA r=-0.16, HAA r=-0.17, AU r=-0.31,
HAU r=-0.2); (vi) the sum score of autonomic disturbances (AA
r=0.23, HAA r=0.12, AU r=0.03, HAU r=0.24); (vii)
medications used at the day of the experiment: (a) tricyclic anti-
depressants (AA r=0.29, HAA r=0.19, AU r=0.19, HAU
r=0.01), (b) opioids (AA r=0.24, HAA r=0.3, AU r=0.02,
HAU r=-0.25), (c) gabapentin and pregabalin (AA r=-0.17,
HAA r=0.07, AU r=0.35, HAU r=0.04), (d) NSAID (AA
r=0.06, HAA r=0.06, AU r=0.16, HAU r=0.07); (viii) age
(AA r=0.10, HAA r=0.21, AU r=0.13, HAU r=0.01).
Signiﬁcant positive correlation was found for (i) the z-score of
adaptation of the affected hand and the z-score of adaptation of
the unaffected hand (r=0.56; P=0.02, Bonferroni corrected); and
(ii) the z-score of hyperalgesic area of the affected hand and the
z-score of hyperalgesic area of the unaffected hand (r=0.71;
P=0.001, Bonferroni corrected). The signiﬁcant correlations are
depicted in Fig. 4.
Discussion
In the present study, we show that CPRS patients display
differential activity in endogenous pain modulatory systems.
Fig. 4 Correlation analysis. Signiﬁcant correlation was found between (A) the z-score of adaptation to the pain stimuli of the affected
and the unaffected hand and (B) the area of experimentally induced pinprick hyperalgesia of the affected and the unaffected hand.
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 The major ﬁndings are (i) that adaptation to repetitive painful high
current density electrical stimuli is decreased in CRPS patients on
both the affected and the unaffected hand compared to healthy
controls and (ii) that the resulting hyperalgesic areas are signiﬁ-
cantly enhanced in CRPS patients on the affected side. These
changes are not correlated to disease duration, pain intensity,
the degree of pre-existing hyperalgesic areas, the presence of
motor symptoms or autonomic disturbances nor any other CRPS
symptom.
However, time course of adaptation and extent of experimen-
tally induced hyperalgesia on the affected hand correlated signiﬁ-
cantly with those on the contralateral unaffected hand. Two major
assertions can be considered as mechanisms underlying these ﬁnd-
ings: (i) the endogenous pain modulatory system in CRPS patients
has to deal with increased nociceptive input from the periphery
and therefore its residual inhibitory capacity is decreased com-
pared with healthy subjects; or (ii) the shift from net inhibition
towards net facilitation in endogenous pain modulating systems
is not a result of CRPS but a risk factor for its appearance
(Edwards, 2005). For the ﬁrst hypothesis, we would expect the
changes to be correlated with individual disease characteristics like
duration or painfulness. However, such a correlation was non-
existent in the present study. This contrasts cortical reorganization
phenomena which result from nociceptive input and were shown
to correlate with pain intensity and pinprick hyperalgesia
(Maihofner et al., 2003, 2004). Nevertheless, we cannot exclude
that the presence of neuropathic pain altered central processing of
nociceptive stimuli, resulting in similar changes in affected and
unaffected regions, for example by alteration of diffuse noxious
inhibitory control system, without a correlation with individual dis-
ease characteristics. Especially pre-existing central sensitization in
CRPS patients may have modiﬁed CNS processing and endogen-
ous modulation of the painful stimuli. For example, LTD and LTP is
induced by repetitive electrical low-frequency stimulation in ani-
mals (Sandkuhler et al., 1997). Such changes in synaptic strength
are suggested to be involved in both the adaptation to repetitive
electrical stimuli (homotopic LTD) and the occurrence of secondary
pinprick hyperalgesia (heterotopic LTP) (Klein et al., 2004, 2006),
although deﬁnitive evidence for contribution of these cellular
mechanisms to the observed effects in humans is lacking. LTD
and LTP mechanisms could be altered in the patient group due
to previous continuous nociceptive input from the CRPS affected
hand. However, in the employed pain model activation of des-
cending naloxone-sensitive and naloxone-insensitive pain modula-
tory systems is more likely to contribute to the observed effects of
adaptation and hyperalgesia (Koppert et al., 2005). There is pro-
found evidence for pronounced and sustained alteration in the
activity of descending controls under the conditions of patholog-
ical pain due to tissue or peripheral nerve damage in the literature
(Baranauskas and Nistri, 1998; Danziger et al., 1999; Woolf and
Mannion, 1999; Millan, 2002). Long term noxious stimulation was
found to be associated with a progressive reinforcement in
mechanisms of descending inhibition, reﬂecting the recruitment
of descending pathways originating in the RVM and noradrenergic
nuclei (Basbaum and Fields, 1984; Millan, 2002). On the other
hand, adaptive changes in descending pain control during chronic
pain can be also of unfavourable character (Millan, 2002).
There is now evidence that persistent activation of descending
facilitation ampliﬁes neuronal sensitization in the dorsal horn and
contributes to chronic painful states (Urban et al., 1996; Mansikka
and Pertovaara, 1997; Wiertelak et al., 1997; Pertovaara, 1998;
Ossipov et al., 2000; Porreca et al., 2001). Subcortical regions
including the thalamus could also be involved in pain modulatory
processes. Single neurons with whole body representation have
been shown in the lateral ventromedial thalamic nucleus. These
neurons relay widespread nociceptive inputs from the medullary
reticular formation to the dorsolateral frontal cortex (Monconduit
et al., 1999; Monconduit and Villanueva, 2005).
The second hypothesis implies that there is a pre-existing inter-
individual difference in the activity in pain modulatory networks.
This assumption is supported by the signiﬁcant correlation of the
amount of adaptation and the extent of experimentally induced
hyperalgesia on the affected hand with those on the contralateral
unaffected hand. However, if differential activity in pain modula-
tory systems is present in CRPS patients one may expect that the
individual degree of activity in these pain inhibitory and facilitatory
systems correlates with individual disease characteristics, e.g. pain
intensity or the area of CRPS-related hyperalgesia. However, we
did not ﬁnd such a correlation in our data. Nevertheless, support-
ive evidence for this hypothesis, i.e. that pre-existing individual
differences in endogenous pain modulation are risk factors for
the development of chronic pain, can be found in the literature
(Edwards, 2005). However, no study was so far performed in
CRPS patients investigating this topic. Basically, endogenous pain
modulation in humans may be tested by the (i) wind up phenom-
enon, thus the application of repeated painful stimuli and consec-
utive measurement of the increase of pain which reﬂects a
pre-stage to central sensitization and is mediated by NMDA recep-
tors (Woolf and Thompson, 1991; Vierck et al., 1997; Edwards,
2005), (ii) by parallel application of two noxious stimuli and mea-
surement of the resulting inhibition (diffuse noxious inhibitory con-
trol, DNIC) (Willer et al., 1984) or by (iii) repetitive application of
noxious stimuli and measurement of the resulting adaptation over
the time course (Koppert et al., 2001, 2005). Interestingly, a pro-
spective study on the development of CRPS after knee arthro-
plasty found correlation between high preoperative pain and
postoperative development of CRPS symptoms (Harden et al.,
2003). Inter-individual and interracial differences in pain sensitivity
are well documented in animals and human (Mogil et al., 1999a,
b, 2005; Edwards et al., 2003; Rolke et al., 2006).
Neurophysiological correlates for these differences in psychophy-
sical pain responses can be found on all levels of the neuraxis
(Coghill et al., 2003; Mogil et al., 2005). These differences can
be inherited (Lotsch and Geisslinger, 2007) or acquired by envi-
ronmental factors or psychosocial processes (Edwards et al., 1985;
MacGregor et al., 1997; Taddio et al., 1997, 2002; Gracely et al.,
2004; Rollman et al., 2004). However, a genetic factor inﬂuencing
pain modulatory systems per se is not known yet. To further prove
the hypothesis of differential endogenous pain modulation as a
risk factor for CRPS development, prospective studies sampling
psychophysical proﬁles of healthy individuals and follow up inves-
tigations for development of CRPS would be needed. Additionally,
there may be also a combination of both, (i) inter-individual dif-
ferences in the activity of descending modulation and (ii) CRPS
10 | Brain 2009: Page 10 of 13 F. Seifert et al.
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 induced changes in the relation of descending inhibition or
facilitation.
Another factor potentially contributing to a differential pain
modulation in CRPS patients is altered autonomic inﬂuence on
descending systems. Interactions between sympathetic and
parasympathetic centres and descending pain modulation has
been reported (Millan, 2002). However, there was no correlation
between autonomic symptoms and parameters resembling pro-
and anti-nociceptive systems in the present study. Finally, an inter-
action of the medication present in the CRPS group interfering
with pain modulatory systems cannot be excluded. However,
one would expect increased adaptation and reduced hyperalgesia
rather than the opposite by pain medication. Furthermore, no sig-
niﬁcant correlation was found between one of the medications
used by the patients (NSAIDS, opioids, adjuvant analgesics) and
the adaptation curves. A contribution of peripheral mechanisms
underlying the observed differences cannot be completely ruled
out. However, this seems unlikely considering the evidence for
centrally mediated mechanisms underlying adaptation (Klein
et al., 2004; Koppert et al., 2005) and secondary mechanical
hyperalgesia in our experimental paradigm (Klede et al., 2003;
Klein et al., 2004; Koppert et al., 2005). In a subgroup analysis
of CRPS I patients only the adaptation behaviour was also signiﬁ-
cantly different. Thus, an explanation of the observed differences
between CRPS patients and controls with the presence of a
damaged peripheral nerve in those three patients with CRPS II is
not justiﬁed, particularly due to the fact that the stimulation was
performed on the dorsum of the hand and not in median nerve
innervated skin.
Further ﬁndings of the present study were a signiﬁcant shift of
the tactile detection threshold induced by the electrical stimulation
in both, patients and controls. Thus, hypoesthesia occurred. This
phenomenon was recently described (De Col and Maihofner,
2008) and could be a result of prompt plastic CNS changes due
to c-ﬁbre input. Also, we found a signiﬁcant difference in the
tactile detection threshold between the affected hand of the
patients and controls. This ﬁnding was expected as hypoesthesia
was clinically present in a majority of our and of other CRPS
patients.
In conclusion, adaptation to repetitive painful high current den-
sity electrical stimuli was found to be decreased in CRPS patients
on both the affected and the unaffected hand compared with
healthy controls. The resulting hyperalgesic areas were signiﬁcantly
enhanced in CRPS patients on the affected side. These changes
were not correlated to individual disease symptoms. Therefore, we
hypothesize that differential activity in endogenous pain modulat-
ing systems could be not only a result of CRPS but may be a risk
factor for its development. To evaluate the underlying mechanisms
in pain modulation, imaging studies focussing on the brainstem
(Tracey and Iannetti, 2006) and, increasingly feasible, the spinal
cord (Brooks and Tracey, 2005) are warranted.
Acknowledgements
We thank Conny Hofmann for excellent technical assistance.
Funding
‘German Research Network on Neuropathic Pain’ (German Federal
Ministry of Education and Research; BMBF); the German Research
Foundation (Deutsche Forschungsgemeinschaft, KFO130); the
ELAN- Fond of the University of Erlangen; EFIC- Gru ¨nenthal
Grant (2006).
References
Akil H, Mayer DJ, Liebeskind JC. Antagonism of stimulation-produced
analgesia by naloxone, a narcotic antagonist. Science 1976; 191:
961–2.
Baranauskas G, Nistri A. Sensitization of pain pathways in the spinal cord:
cellular mechanisms. Prog Neurobiol 1998; 54: 349–65.
Baron R, Schattschneider J, Binder A, Siebrecht D, Wasner G. Relation
between sympathetic vasoconstrictor activity and pain and hyperalge-
sia in complex regional pain syndromes: a case-control study. Lancet
2002; 359: 1655–60.
Basbaum AI, Fields HL. Endogenous pain control mechanisms: review
and hypothesis. Ann Neurol 1978; 4: 451–62.
Basbaum AI, Fields HL. Endogenous pain control systems: brainstem
spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984;
7: 309–38.
Behbehani MM, Fields HL. Evidence that an excitatory connection
between the periaqueductal gray and nucleus raphe magnus mediates
stimulation produced analgesia. Brain Res 1979; 170: 85–93.
Beitz AJ. The organization of afferent projections to the midbrain peria-
queductal gray of the rat. Neuroscience 1982; 7: 133–59.
Benarroch EE. Descending monoaminergic pain modulation: bidirectional
control and clinical relevance. Neurology 2008; 71: 217–21.
Birklein F. Complex regional pain syndrome. J Neurol 2005; 252: 131–8.
Birklein F, Schmelz M, Schifter S, Weber M. The important role of neu-
ropeptides in complex regional pain syndrome. Neurology 2001; 57:
2179–84.
Boivie J, Meyerson BA. A correlative anatomical and clinical study of pain
suppression by deep brain stimulation. Pain 1982; 13: 113–26.
Brooks J, Tracey I. From nociception to pain perception: imaging the
spinal and supraspinal pathways. J Anat 2005; 207: 19–33.
Chen J, Sandkuhler J. Induction of homosynaptic long-term depression at
spinal synapses of sensory a delta-ﬁbers requires activation of meta-
botropic glutamate receptors. Neuroscience 2000; 98: 141–8.
Coghill RC, McHafﬁe JG, Yen YF. Neural correlates of interindividual
differences in the subjective experience of pain. Proc Natl Acad Sci
USA 2003; 100: 8538–42.
Danziger N, Weil-Fugazza J, Le Bars D, Bouhassira D. Alteration of des-
cending modulation of nociception during the course of monoarthritis
in the rat. J Neurosci 1999; 19: 2394–400.
De Col R, Maihofner C. Centrally mediated sensory decline induced by
differential C-ﬁber stimulation. Pain 2008; 138: 556–64.
Edwards RR. Individual differences in endogenous pain modulation as a
risk factor for chronic pain. Neurology 2005; 65: 437–43.
Edwards RR, Ness TJ, Weigent DA, Fillingim RB. Individual differences in
diffuse noxious inhibitory controls (DNIC): association with clinical
variables. Pain 2003; 106: 427–37.
Edwards PW, Zeichner A, Kuczmierczyk AR, Boczkowski J. Familial pain
models: the relationship between family history of pain and current
pain experience. Pain 1985; 21: 379–84.
Filitz J, Ihmsen H, Gunther W, Troster A, Schwilden H, Schuttler J, et al.
Supra-additive effects of tramadol and acetaminophen in a human
pain model. Pain 2008; 136: 262–70.
Gracely RH, Geisser ME, Giesecke T, Grant MA, Petzke F, Williams DA,
et al. Pain catastrophizing and neural responses to pain among persons
with ﬁbromyalgia. Brain 2004; 127: 835–43.
Pain modulation in complex-regional pain syndrome Brain 2009: Page 11 of 13 | 11
b
y
 
g
u
e
s
t
 
o
n
 
O
c
t
o
b
e
r
 
3
1
,
 
2
0
1
4
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 Gray TS, Magnuson DJ. Peptide immunoreactive neurons in the amyg-
dala and the bed nucleus of the stria terminalis project to the midbrain
central gray in the rat. Peptides 1992; 13: 451–60.
Harden RN, Bruehl S, Stanos S, Brander V, Chung OY, Saltz S, et al.
Prospective examination of pain-related and psychological predictors
of CRPS-like phenomena following total knee arthroplasty: a prelimin-
ary study. Pain 2003; 106: 393–400.
Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diag-
nostic criteria for complex regional pain syndrome. Pain Med 2007; 8:
326–31.
Hardy SG, Leichnetz GR. Cortical projections to the periaqueductal gray
in the monkey: a retrograde and orthograde horseradish peroxidase
study. Neurosci Lett 1981; 22: 97–101.
Ikeda H, Heinke B, Ruscheweyh R, Sandkuhler J. Synaptic plasticity in
spinal lamina I projection neurons that mediate hyperalgesia. Science
2003; 299: 1237–40.
Ikeda H, Stark J, Fischer H, Wagner M, Drdla R, Jager T, et al. Synaptic
ampliﬁer of inﬂammatory pain in the spinal dorsal horn. Science 2006;
312: 1659–62.
Janig W, Baron R. Complex regional pain syndrome is a disease of the
central nervous system. Clin Auton Res 2002; 12: 150–64.
Kidd BL, Urban LA. Mechanisms of inﬂammatory pain. Br J Anaesth
2001; 87: 3–11.
Klede M, Handwerker HO, Schmelz M. Central origin of secondary
mechanical hyperalgesia. J Neurophysiol 2003; 90: 353–9.
Klein T, Magerl W, Hopf HC, Sandkuhler J, Treede RD. Perceptual cor-
relates of nociceptive long-term potentiation and long-term depression
in humans. J Neurosci 2004; 24: 964–71.
Klein T, Magerl W, Rolke R, Treede RD. Human surrogate models of
neuropathic pain. Pain 2005; 115: 227–33.
Klein T, Magerl W, Treede RD. Perceptual correlate of nociceptive long-
term potentiation (LTP) in humans shares the time course of early-LTP.
J Neurophysiol 2006; 96: 3551–5.
Koltzenburg M, Lundberg LE, Torebjork HE. Dynamic and static compo-
nents of mechanical hyperalgesia in human hairy skin. Pain 1992; 51:
207–19.
Koppert W, Dern SK, Sittl R, Albrecht S, Schuttler J, Schmelz M. A new
model of electrically evoked pain and hyperalgesia in human skin: the
effects of intravenous alfentanil, S(+)-ketamine, and lidocaine.
Anesthesiology 2001; 95: 395–402.
Koppert W, Filitz J, Troster A, Ihmsen H, Angst M, Flor H, et al.
Activation of naloxone-sensitive and -insensitive inhibitory systems in
a human pain model. J Pain 2005; 6: 757–64.
Lang S, Klein T, Magerl W, Treede RD. Modality-speciﬁc sensory
changes in humans after the induction of long-term potentiation
(LTP) in cutaneous nociceptive pathways. Pain 2007; 128: 254–63.
Lotsch J, Geisslinger G. Current evidence for a modulation of nociception
by human genetic polymorphisms. Pain 2007; 132: 18–22.
MacGregor AJ, Grifﬁths GO, Baker J, Spector TD. Determinants of pres-
sure pain threshold in adult twins: evidence that shared environmental
inﬂuences predominate. Pain 1997; 73: 253–7.
Maihofner C, Handwerker HO, Neundorfer B, Birklein F. Patterns of
cortical reorganization in complex regional pain syndrome. Neurology
2003; 61: 1707–15.
Maihofner C, Handwerker HO, Neundorfer B, Birklein F. Cortical reor-
ganization during recovery from complex regional pain syndrome.
Neurology 2004; 63: 693–701.
Mansikka H, Pertovaara A. Supraspinal inﬂuence on hindlimb withdrawal
thresholds and mustard oil-induced secondary allodynia in rats. Brain
Res Bull 1997; 42: 359–65.
Mason P. Ventromedial medulla: pain modulation and beyond. J Comp
Neurol 2005; 493: 2–8.
Millan MJ. Descending control of pain. Prog Neurobiol 2002; 66:
355–474.
Mogil JS, Miermeister F, Seifert F, Strasburg K, Zimmermann K,
Reinold H, et al. Variable sensitivity to noxious heat is mediated by
differential expression of the CGRP gene. Proc Natl Acad Sci USA
2005; 102: 12938–43.
Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, et al. Heritability
of nociception I: responses of 11 inbred mouse strains on 12 measures
of nociception. Pain 1999a; 80: 67–82.
Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, et al. Heritability
of nociception II. ‘Types’ of nociception revealed by genetic correlation
analysis. Pain 1999b; 80: 83–93.
Monconduit L, Bourgeais L, Bernard JF, Le Bars D, Villanueva L.
Ventromedial thalamic neurons convey nociceptive signals from the
whole body surface to the dorsolateral neocortex. J Neurosci 1999;
19: 9063–72.
Monconduit L, Villanueva L. The lateral ventromedial thalamic nucleus
spreads nociceptive signals from the whole body surface to layer I of
the frontal cortex. Eur J Neurosci 2005; 21: 3395–402.
Namer B, Seifert F, Handwerker HO, Maihofner C. TRPA1 and TRPM8
activation in humans: effects of cinnamaldehyde and menthol.
Neuroreport 2005; 16: 955–9.
Ossipov MH, Hong Sun T, Malan P Jr, Lai J, Porreca F. Mediation of
spinal nerve injury induced tactile allodynia by descending facilitatory
pathways in the dorsolateral funiculus in rats. Neurosci Lett 2000; 290:
129–32.
Pertovaara A. A neuronal correlate of secondary hyperalgesia in the rat
spinal dorsal horn is submodality selective and facilitated by suprasp-
inal inﬂuence. Exp Neurol 1998; 149: 193–202.
Pertovaara A. Plasticity in descending pain modulatory systems. Prog
Brain Res 2000; 129: 231–42.
Pleger B, Tegenthoff M, Ragert P, Forster AF, Dinse HR, Schwenkreis P,
et al. Sensorimotor retuning [corrected] in complex regional pain syn-
drome parallels pain reduction. Ann Neurol 2005; 57: 425–9.
Porreca F, Burgess SE, Gardell LR, Vanderah TW, Malan TP Jr,
Ossipov MH, et al. Inhibition of neuropathic pain by selective ablation
of brainstem medullary cells expressing the mu-opioid receptor. J
Neurosci 2001; 21: 5281–8.
Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary des-
cending facilitation. Trends Neurosci 2002; 25: 319–25.
Proudﬁt HK, Anderson EG. Morphine analgesia: blockade by raphe
magnus lesions. Brain Res 1975; 98: 612–18.
Ren K, Dubner R. Descending modulation in persistent pain: an update.
Pain 2002; 100: 1–6.
Reynolds DV. Surgery in the rat during electrical analgesia induced by
focal brain stimulation. Science 1969; 164: 444–5.
Rolke R, Baron R, Maier C, Tolle TR, Treede RD, Beyer A, et al.
Quantitative sensory testing in the German Research Network on
Neuropathic Pain (DFNS): standardized protocol and reference
values. Pain 2006; 123: 231–43.
Rollman GB, Abdel-Shaheed J, Gillespie JM, Jones KS. Does past pain
inﬂuence current pain: biological and psychosocial models of sex dif-
ferences. Eur J Pain 2004; 8: 427–33.
Sandkuhler J. Understanding LTP in pain pathways. Mol Pain 2007; 3: 9.
Sandkuhler J, Chen JG, Cheng G, Randic M. Low-frequency stimulation
of afferent Adelta-ﬁbers induces long-term depression at primary
afferent synapses with substantia gelatinosa neurons in the rat. J
Neurosci 1997; 17: 6483–91.
Sandkuhler J, Gebhart GF. Relative contributions of the nucleus raphe
magnus and adjacent medullary reticular formation to the inhibition by
stimulation in the periaqueductal gray of a spinal nociceptive reﬂex in
the pentobarbital-anesthetized rat. Brain Res 1984; 305: 77–87.
Schattschneider J, Binder A, Siebrecht D, Wasner G, Baron R. Complex
regional pain syndromes: the inﬂuence of cutaneous and deep somatic
sympathetic innervation on pain. Clin J Pain 2006a; 22: 240–4.
Schattschneider J, Hartung K, Stengel M, Ludwig J, Binder A, Wasner G,
et al. Endothelial dysfunction in cold type complex regional pain syn-
drome. Neurology 2006b; 67: 673–5.
Schmelz M, Schmid R, Handwerker HO, Torebjork HE. Encoding of
burning pain from capsaicin-treated human skin in two categories of
unmyelinated nerve ﬁbres. Brain 2000; 123 (Pt 3): 560–71.
Stanton-Hicks M, Janig W, Hassenbusch S, Haddox JD, Boas R,
Wilson P. Reﬂex sympathetic dystrophy: changing concepts and tax-
onomy. Pain 1995; 63: 127–33.
12 | Brain 2009: Page 12 of 13 F. Seifert et al.
b
y
 
g
u
e
s
t
 
o
n
 
O
c
t
o
b
e
r
 
3
1
,
 
2
0
1
4
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 Starowicz K, Maione S, Cristino L, Palazzo E, Marabese I, Rossi F, et al.
Tonic endovanilloid facilitation of glutamate release in brainstem -
descending antinociceptive pathways. J Neurosci 2007; 27: 13739–49.
Stein C, Mendl G. The German counterpart to McGill pain questionnaire.
Pain 1988; 32: 251–5.
Taddio A, Katz J, Ilersich AL, Koren G. Effect of neonatal circumcision on
pain response during subsequent routine vaccination. Lancet 1997;
349: 599–603.
Taddio A, Shah V, Gilbert-MacLeod C, Katz J. Conditioning and hyper-
algesia in newborns exposed to repeated heel lances. JAMA 2002;
288: 857–61.
Tracey I, Iannetti GD. Brainstem functional imaging in humans. Suppl
Clin Neurophysiol 2006; 58: 52–67.
Urban MO, Gebhart GF. Central mechanisms in pain. Med Clin North
Am 1999a; 83: 585–96.
Urban MO, Gebhart GF. Supraspinal contributions to hyperalgesia. Proc
Natl Acad Sci USA 1999b; 96: 7687–92.
Urban MO, Jiang MC, Gebhart GF. Participation of central descending
nociceptive facilitatory systems in secondary hyperalgesia produced by
mustard oil. Brain Res 1996; 737: 83–91.
Valet M, Sprenger T, Boecker H, Willoch F, Rummeny E, Conrad B, et al.
Distraction modulates connectivity of the cingulo-frontal cortex
and the midbrain during pain—an fMRI analysis. Pain 2004; 109:
399–408.
Vanegas H. To the descending pain-control system in rats, inﬂammation-
induced primary and secondary hyperalgesia are two different things.
Neurosci Lett 2004; 361: 225–8.
Vierck CJ Jr, Cannon RL, Fry G, Maixner W, Whitsel BL. Characteristics
of temporal summation of second pain sensations elicited by brief
contact of glabrous skin by a preheated thermode. J Neurophysiol
1997; 78: 992–1002.
Weber M, Birklein F, Neundorfer B, Schmelz M. Facilitated neurogenic
inﬂammation in complex regional pain syndrome. Pain 2001; 91:
251–7.
Weidner C, Schmelz M, Schmidt R, Hansson B, Handwerker HO,
Torebjork HE. Functional attributes discriminating mechano-insensitive
and mechano-responsive C nociceptors in human skin. J Neurosci
1999; 19: 10184–90.
Wiertelak EP, Roemer B, Maier SF, Watkins LR. Comparison of the
effects of nucleus tractus solitarius and ventral medial medulla lesions
on illness-induced and subcutaneous formalin-induced hyperalgesias.
Brain Res 1997; 748: 143–50.
Willer JC, Roby A, Le Bars D. Psychophysical and electrophysiological
approaches to the pain-relieving effects of heterotopic nociceptive
stimuli. Brain 1984; 107 (Pt 4): 1095–112.
Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechan-
isms, and management. Lancet 1999; 353: 1959–64.
Woolf CJ, Thompson SW. The induction and maintenance of central
sensitization is dependent on N-methyl-D-aspartic acid receptor acti-
vation; implications for the treatment of post-injury pain hypersensi-
tivity states. Pain 1991; 44: 293–9.
Ziegler EA, Magerl W, Meyer RA, Treede RD. Secondary hyperalgesia to
punctate mechanical stimuli. Central sensitization to A-ﬁbre nociceptor
input. Brain 1999; 122 (Pt 12): 2245–57.
Pain modulation in complex-regional pain syndrome Brain 2009: Page 13 of 13 | 13
b
y
 
g
u
e
s
t
 
o
n
 
O
c
t
o
b
e
r
 
3
1
,
 
2
0
1
4
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 